Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Short activities reduced again
View:
Post by Golddetector on Jan 17, 2022 9:26am

Short activities reduced again

Short activities for tbp for 1st two weeks of Jan. Reduced again for 2nd period. link below. Gl longs


https://shortdata.ca/stock/TBP.TO

Comment by Elouali on Jan 17, 2022 9:55am
Gl longs = Keep faith despite we are not good at all .
Comment by SamV21 on Jan 17, 2022 11:58am
Best to cover before it halts trading and before Tetra files chapter 11 then they get nothing . Guy has no time for shareholders he is too busy moving what he can into his holding company 9315-4466  Inc. which makes over 733,000 us a year.Tetra has no money to complete Qixleef Phase 2 trials and is worth nothing till the end of Phase 3 which will cost 100s of millions to complete .Reduvo is ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities